Report #2899098

Received Jun 5, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 73 yrs
State: ND
Recovered: Unknown
Vaccinated: Jun 2, 2026
Onset: Jun 2, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	24M94	—

Symptoms (1)

Expired product administered

Symptom narrative

Arexvy expired dose administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 73-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) suspension for injection (batch number 24M94 with expiry date 03-NOV-2025) for prophylaxis. On 02-JUN-2026, the patient received Arexvy. On 02-JUN-2026, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Arexvy expired dose administration). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 02-JUN-2026 Pharmacist wanted to know how to proceed with a patient that received an expired dose of Arexvy.